Exactly, I completely agree. The valuation of IMU and other biotech companies is huge compared to PEB. Lots of retailer holders (including myself) thought it was overvalued at 800m until I investigated some comparable ASX firms. Now I think it's cheap! I'm not expecting volumes to ramp up drastically this FY but the next two should see big growth in revenue. They receive $700USD for a test and it costs them $70USD to produce. - and their manufacturing is in the US already.
IPO - Pacific Edge Limited - 23 September 2021 #, page-14
Add PEB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.5¢ | $999 | 7.994K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 4224 | 1 |
View Market Depth
| Last trade - 10.19am 15/11/2024 (20 minute delay) ? |
| PEB (ASX) Chart |